LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C2

References

• Somintara S, Leardkamolkarn V, Suttiarporn P, Mahatheeranont S. Anti-tumor and immune enhancing activities of rice bran gramisterol on acute myelogenous leukemia. PLoS One. 2016;11:e0146869–e. doi:10.1371/journal.pone.0146869.
   PubMed Web of Science ®Google Scholar
• Bi L, Sun L, Jin Z, Zhang S, Shen Z. MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia. Oncol Lett. 2018;15:5611–5619. doi:10.3892/ol.2018.8050.
   PubMed Web of Science ®Google Scholar
• Li S, Mason CE, Melnick A. Genetic and epigenetic heterogeneity in acute myeloid leukemia. Curr Opin Genet Dev. 2016;36:100–106. doi:10.1016/j.gde.2016.03.011.
   PubMed Web of Science ®Google Scholar
• Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89–101. doi:10.1038/nrc989.
   PubMed Web of Science ®Google Scholar
• Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13:e249–e58. doi:10.1016/S1470-2045(12)70073-6.
   PubMed Web of Science ®Google Scholar
• Monroig PDC, Chen L, Zhang S, Calin GA. Small molecule compounds targeting miRNAs for cancer therapy. Adv Drug Deliv Rev. 2015;81:104–116. doi:10.1016/j.addr.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Minervini A, Specchia G. SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. J Hematol Oncol. 2012;5(1):48. doi:10.1186/1756-8722-5-48.
   PubMedGoogle Scholar
• Liu L, Ren W, Chen K. MiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cells. Cell Physiol Biochem. 2017;41:1981–1992. doi:10.1159/000475277.
   PubMed Web of Science ®Google Scholar
• Xiao J, Lv D, Zhou J, Bei Y, Chen T, Hu M, Zhou Q, Fu S, Huang Q. Therapeutic Inhibition of miR-4260 suppresses colorectal cancer via targeting MCC and SMAD4. Theranostics. 2017;7(7):1901–1913. doi:10.7150/thno.19168.
   PubMed Web of Science ®Google Scholar
• Morlando M, Ballarino M, Fatica A. Long non-coding RNAs: new players in hematopoiesis and leukemia. Front Med (Lausanne). 2015;2:23. doi:10.3389/fmed.2015.00061.
   PubMed Web of Science ®Google Scholar
• Cheetham SW, Gruhl F, Mattick JS, Dinger ME. Long noncoding RNAs and the genetics of cancer. Br J Cancer. 2013;108:2419–2425. doi:10.1038/bjc.2013.233.
   PubMed Web of Science ®Google Scholar
• Clark MB, Mattick JS. Long noncoding RNAs in cell biology. Semin Cell Dev Biol. 2011;22:366–376. doi:10.1016/j.semcdb.2011.01.001.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Z, Sheng F, Yin Z. MYC upregulated LINC00319 promotes human acute myeloid leukemia (AML) cells growth through stabilizing SIRT6. Biochem Biophys Res Commun. 2018;509(1):314–321.
   Web of Science ®Google Scholar
• Zhang T-J, Zhou J-D, Zhang W, Lin J, Ma J-C, Wen X-M, Yuan Q, Li -X-X, Xu Z-J, Qian J, et al. H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia. Clin Epigenetics. 2018;10(1):47. doi:10.1186/s13148-018-0486-z.
   PubMedGoogle Scholar
• Chen L, Wang W, Cao L, Li Z, Wang X. Long non-coding RNA CCAT1 acts as a competing endogenous RNA to regulate cell growth and differentiation in acute myeloid leukemia. Mol Cells. 2016;39:330–336.
   PubMed Web of Science ®Google Scholar
• Horisberger JD, Rossier BC. Aldosterone regulation of gene transcription leading to control of ion transport. Hypertension. 1992;19:221–227. doi:10.1161/01.HYP.19.3.221.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Che X, Yang N, Bai Z, Wu Y, Zhao L, Pei H. miR-135b-5p promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. Biomed Pharmacother. 2017;96:S0753332217353143. doi:10.1016/j.biopha.2017.11.074.
   Web of Science ®Google Scholar
• Zhao Z, Zhang M, Duan X, Deng T, Qiu H, Zeng G. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma. J Cell Physiol. 2018;233(10):6825–6838. doi:10.1002/jcp.v233.10.
   PubMed Web of Science ®Google Scholar
• Long MD, Campbell MJ. Pan-cancer analyses of the nuclear receptor superfamily. Nucl Receptor Res. 2015;2:101182. doi:10.11131/2015/101182.
   PubMedGoogle Scholar
• Tan J, Qiu K, Li M, Liang Y. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Lett. 2015;589:3175–3181. doi:10.1016/j.febslet.2015.08.020.
   PubMed Web of Science ®Google Scholar
• Tian W, Du Y, Ma Y, Gu L, Zhou J, Deng D. MALAT1-miR663a negative feedback loop in colon cancer cell functions through direct miRNA-lncRNA binding. Cell Death Dis. 2018;9:857. doi:10.1038/s41419-018-0925-y.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–358. doi:10.1016/j.cell.2011.07.014.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Chen Z, Li Y, He A, He S, Gong Y, Li X, Zhou L. Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA. J Exp Clin Cancer Res. 2018;37(1):273. doi:10.1186/s13046-018-0921-1.
   PubMedGoogle Scholar
• Yin X, Huang S, Zhu R, Fan F, Sun C, Hu Y. Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia. Cancer Cell Int. 2018;18:122. doi:10.1186/s12935-018-0621-0.
   PubMed Web of Science ®Google Scholar
• Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358(18):1909–1918. doi:10.1056/NEJMoa074306.
   PubMed Web of Science ®Google Scholar
• Woods BA, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Immunol Rev. 2015;263:22–35. doi:10.1111/imr.12246.
   PubMed Web of Science ®Google Scholar
• Chen L, Jiang X, Chen H, Han Q, Liu C, Sun M. microRNA-628 inhibits the proliferation of acute myeloid leukemia cells by directly targeting IGF-1R. Onco Targets Ther. 2019;12:907–919. doi:10.2147/OTT.S192137.
   PubMed Web of Science ®Google Scholar
• Espadinha AS, Prouzet-Mauléon V, Claverol S, Lagarde V, Bonneu M, Mahon FX, Cardinaud B. A tyrosine kinase-STAT5-miR21-PDCD4 regulatory axis in chronic and acute myeloid leukemia cells. Oncotarget. 2017;8:76174–76188. doi:10.18632/oncotarget.19192.
   PubMedGoogle Scholar